Fibroma epidemiology and demographics: Difference between revisions
Simrat Sarai (talk | contribs) No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Fibroma}} | {{Fibroma}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{Simrat}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 21:09, 29 February 2016
|
Fibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Fibroma epidemiology and demographics |
|
Risk calculators and risk factors for Fibroma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Epidemiology and Demographics
Non-ossifying Fibroma
Prevalence
The prevalence of fibroma is estimated to be [number] cases annually.
Incidence
Age
Non-ossifying fibromas are the most common fibrous bony lesions in children and adolescents, with a peak incidence at 10-15 years old. Non-ossifying fibromas are not seen beyond the age of 30 years, as they spontaneously heal.
Gender
Males are more commonly affected with non-ossifying fibromas than females. The male to female ratio is approximately 2 to 1.